优格药丸通过抑制Th17反应和IL-17/NF-κB通路来预防卵巢切除引起的骨损失
Peng Zhang1, Luting Lin2, Ningrui Wang2
1Department of Orthopedics, Hangzhou Red Cross Hospital, Hangzhou, China.
Annals of medicine
|July 7, 2025
概括
优格丸 (YGPs) 通过抑制Th17反应和IL-17/NF-κB通路来预防骨质疏松症的骨损失. 这种传统中医药抑制骨质细胞的形成和功能,提供了一种新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症是一种代谢性骨病,其特征是骨质细胞过度形成和骨质损失.
- 药丸 (YGP) 是一种具有已知的抗骨质疏松作用的传统中医配方,但其机制尚不清楚.
研究的目的:
- 阐明YGP在治疗骨质疏松症中的潜在分子机制.
- 调查YGP对骨免疫力的影响,特别是Th17反应和骨质细胞形成.
主要方法:
- 卵巢切除的小鼠模型用Alcian蓝色血素染色和微型CT扫描.
- 网络分析以确定年轻人医生-骨质疏松症目标.
- 流细胞计和免疫组织化学测试以评估Th17反应标记物 (CD4,IL-17A,RANKL,RORγt).
- 在体外和体内评估骨质细胞形成和功能标志物 (p-P65,NFATc1,CTSK) 通过IHC和免疫光.
主要成果:
- 在卵巢切除小鼠模型中,YGP显著防止了骨损失.
- 鉴定出白蛋白-17 (IL-17) 是一个关键的标,与Th17细胞和NF-κB通路有关.
- 通过抑制IL-17 / NF-κB通路,YGP治疗抑制了提升的Th17反应,并减少了骨质细胞的形成和功能.
结论:
- 抗骨质疏松剂通过调节骨质免疫力来发挥抗骨质疏松作用.
- 该机制涉及抑制Th17反应和IL-17/NF-κB通路,以抑制骨质细胞形成和骨质损失.
相关概念视频
Hormonal Control of the Ovarian Cycle
3.2K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
3.2K
Hormones and Bone Tissue
3.0K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.0K
Oogenesis
64.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.5K
Drugs for Treatment of Ulcerative Colitis in IBD
242
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
242
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
600
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
600
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275


